Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

Publication Venue For
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment.. 61:552-562. 2020
- Hospice Admission and Survival After ¹⁸ F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.. 59:427-433. 2018
- ACR and SNMMI Joint Credentialing Statement for PET/MRI of the Body.. 58:1174-1176. 2017
- Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up ¹⁸ F-FDG PET/CT Scans in Oncology Patients.. 58:737-743. 2017
- SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer.. 58:11-12. 2017
- 18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.. 57:855-860. 2016
- Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.. 56:1137-1143. 2015
- ¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.. 56:989-994. 2015
- American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain.. 56:642-645. 2015
- 18F-FDG PET/CT and lung cancer: value of fourth and subsequent posttherapy follow-up scans for patient management.. 56:204-208. 2015
- Reply: Qualitative 18F-FDG PET/CT response evaluation after chemotherapy or radiotherapy for head and neck squamous cell carcinoma: is there an equivocal group?. 55:2081-2082. 2014
- Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.. 55:1411-1416. 2014
- Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.. 55:1062-1068. 2014
- A high-performance SPECT-CT system for dedicated molecular breast imaging. 52:673-674. 2011
- Combination of converging collimators for high-sensitivity brain SPECT.. 50:1548-1556. 2009
- Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.. 49:1628-1635. 2008
- Imaging biomarkers roundtable report. 49:22N-+. 2008
- Collaborations in the development and validation of imaging biomarkers.. 49:36N-37N. 2008
- Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.. 49:517-523. 2008
- Recommendations on the use of 18F-FDG PET in oncology.. 49:480-508. 2008
- Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.. 49:30-38. 2008
- Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.. 48:1492-1500. 2007
- Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 3: alpha-particle-induced radiolytic effects on the chemical behavior of (211)At.. 48:1190-1196. 2007
- Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.. 48:896-901. 2007
- NIH MICAD initiative and guest author program opportunities.. 48:19N. 2007
- Commentary. 48. 2007
- PET/CT in cancer patient management. Commentary.. 48 Suppl 1:1S. 2007
- On-axis sensitivity and resolution of a slit-slat collimator.. 47:1884-1890. 2006
- Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.. 47:1607-1611. 2006
- Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.. 47:1238-1240. 2006
- Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.. 47:1059-1066. 2006
- Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).. 47:989-998. 2006
- Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results.. 47:912-918. 2006
- Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.. 47:1007-1015. 2006
- Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 2: radiolytic effects of 211At alpha-particles influence N-succinimidyl 3-211AT-astatobenzoate synthesis.. 46:1393-1400. 2005
- Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.. 46:1042-1051. 2005
- Radiopharmaceutical chemistry of targeted radiotherapeutics, part 1: effects of solvent on the degradation of radiohalogenation precursors by 211At alpha-particles.. 46:700-706. 2005
- Problems created in attenuation-corrected SPECT images by artifacts in attenuation maps: a simulation study.. 46:335-343. 2005
- Current status of therapy of solid tumors: brain tumor therapy.. 46 Suppl 1:151S-156S. 2005
- Prediction of death and nonfatal myocardial infarction in high-risk patients: a comparison between the Duke treadmill score, peak exercise radionuclide angiography, and SPECT perfusion imaging.. 46:5-11. 2005
- The additive value of combined assessment of myocardial perfusion and ventricular function studies.. 45:1721-1724. 2004
- Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.. 45:108-115. 2004
- In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter.. 44:1827-1838. 2003
- Initial X-ray design considerations for application specific emission and transmission tomography (ASETT) of the breast.. 44:287P-287P. 2003
- Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images.. 44:792-805. 2003
- Mammotomography with pinhole incomplete circular orbit SPECT.. 44:583-593. 2003
- Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients.. 44:134-139. 2003
- Feasibility of application specific emission & transmission tomography (ASETT) of the breast.. 43:12P-12P. 2002
- Negatively charged substituent-bearing acylation agent for the radiohalogenation of mAbs.. 43:366P-366P. 2002
- Radioimmunotherapy of refractory non-Hodgkin's lymphoma with I-131-labeled chimeric 81C6 anti-tenascin monoclonal antibody: Dosimetry study.. 43:313P-313P. 2002
- Receiver operating characteristic evaluation of triple-head 360 degree versus dual-head 180 degree myocardial SPECT acquisition.. 43:53P-53P. 2002
- Single and double knife-edge pinhole collimators for SPECT imaging of small volumes.. 43:223P-224P. 2002
- Synthesis and in vitro evaluation of glycated octreotate conjugates labeled with radioiodine and At-211 via a tin precursor.. 43:92P-92P. 2002
- Pharmacokinetics and radiation dosimetry of 18F-fluorocholine.. 43:92-96. 2002
- Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.. 42:1805-1814. 2001
- High-level production of alpha-particle-emitting (211)At and preparation of (211)At-labeled antibodies for clinical use.. 42:1508-1515. 2001
- Comparison of PET oxygen extraction fraction methods for the prediction of stroke risk.. 42:1195-1197. 2001
- Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables.. 42:871-877. 2001
- Analytic determination of pinhole collimator sensitivity with penetration.. 42:140P-140P. 2001
- Characteristics of a rotating gamma camera with 1-inch sodium iodide detectors for SPECT and PET.. 42:98P-98P. 2001
- Dedicated PICO-SPECT: An approach to clinical breast imaging.. 42:207P-208P. 2001
- Dedicated breast imaging with an ASET: Application specific emission tomograph.. 42:97P-97P. 2001
- Dynamic Cardiac Beating Heart Phantom.. 42:165P-165P. 2001
- Modeling respiratory motion in the superquadric-based cardiac-thorax phantom.. 42:141P-141P. 2001
- Radioimmunotherapy of recurrent glioma patients using alpha-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody.. 42:121P-122P. 2001
- Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.. 42:535-542. 2001
- FDG PET imaging in patients with pathologically verified dementia.. 41:1920-1928. 2000
- Comparing MRS and PET.. 41:1363. 2000
- Myocardial hibernation and stunning: still much to learn.. 41:1235-1236. 2000
- Cardiac SPECT attenuation correction using an integrated x-ray CT/dual-head scintillation camera system.. 41:22P-22P. 2000
- Cost-effectiveness analysis of therapy for symptomatic carotid occlusion: PET screening before selective extracranial-to-intracranial bypass versus medical treatment.. 41:800-807. 2000
- Effects of reconstruction methods and attenuation correction on hot bladder artifacts in PET.. 41:194P-194P. 2000
- Microdosimetry of alpha-particle-emitting At-211-labelled monoclonal antibody (MAb) using histological images of malignant brain tumors.. 41:84P-84P. 2000
- Transmission scanning system for a gamma camera coincidence scanner.. 41:692-699. 2000
- Receiver operating characteristic evaluation of iterative reconstruction with attenuation correction in 99mTc-sestamibi myocardial SPECT images.. 41:502-513. 2000
- 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.. 40:1197-1203. 1999
- Small-animal PET: advent of a new era of PET research.. 40:1176-1179. 1999
- Comparison of diagnostic performance in brain PET imaging using 3D and 2D acquisition modes.. 40:118P-118P. 1999
- Design and performance of a self-shielded CS-137 multiple-point-source transmission scanning system for rotating gamma camera.. 40:34P-34P. 1999
- Effect and correction of detector sag in SPECT systems.. 40:285P-285P. 1999
- High-resolution in vivo SPECT imaging of I-131 biodistributions using a rotating parallel-hole collimator.. 40:34P-35P. 1999
- Regional FDG uptake, attenuation, and geometries measurements for whole body phantom design.. 40:281P-281P. 1999
- Ultra-high resolution SPECT images with uranium pinhole collimators.. 40:34P-34P. 1999
- Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors.. 40:631-638. 1999
- Coincidence imaging with a dual-head scintillation camera.. 40:432-441. 1999
- Locally increased uptake of fluorine-18fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors. 39:1376-1380. 1998
- Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors.. 39:1376-1380. 1998
- Transmission imaging for nonuniform attenuation correction using a three-headed SPECT camera.. 39:1105-1110. 1998
- A comparison of OSEM and ICD for iterative reconstruction of SPECT brain images.. 39:79P-79P. 1998
- Composite quadric-based object model for SPECT Monte Carlo simulation.. 39:121P-121P. 1998
- Detection of recurrent brain tumor: Comparison of MR registered camera-based (CB) and dedicated (D) PET images.. 39:257P-257P. 1998
- Human IgG(2) constant region enhances the in vivo stability of monoclonal antibody 81C6 compared to its murine parent.. 39:77P-77P. 1998
- Lesion detection using nonattenuation corrected dedicated and camera-based PET compared with attenuation corrected dedicated PET.. 39:109P-109P. 1998
- Minimizing cardiac motion blurring and improving image signal-to-background using gated SPECT and statistically based 3D morphological deformations.. 39:121P-121P. 1998
- Myocardial kinetics of meta-[I-131]iodobenzylguanidine in an adriamycin cardiomyopathy rat model.. 39:47P-47P. 1998
- N.C.A. 5-Iodo-1(2-deoxy,2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU): Tissue uptake in D-54 glioma xenograft mouse model and cytotoxicity to D-247 glioma cells in vitro.. 39:104P-105P. 1998
- Positron imaging of pulmonary nodules: Phantom study.. 39:108P-108P. 1998
- Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent.. 39:227P-227P. 1998
- Pretargeted radioimmunotherapy using anti-tenascin 81C6-streptavidin conjugates and radiolabeled biotin: Preparation of reagents.. 39:105P-106P. 1998
- Quantitative imaging of iodine-131 distributions in brain tumors with pinhole SPECT: a phantom study.. 39:856-864. 1998
- Transmission scanning on a gamma camera coincidence imaging system.. 39:92P-93P. 1998
- Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit.. 39:647-650. 1998
- Effect of registration errors between transmission and emission scans on a SPECT system using sequential scanning.. 39:365-373. 1998
- A PC-based patient-specific external dose calculation method for outpatient I-131 therapy.. 39:277P-277P. 1998
- Prognosis by measurements of left ventricular function during exercise. 39:140-146. 1998
- Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group.. 39:140-146. 1998
- A method for labeling internalizing antibodies with astatine-211.. 38:15-15. 1997
- A novel dual detector probe for gamma-ray guided intraoperative beta imaging.. 38:21-21. 1997
- Anatomical variations affecting cardiac imaging in female patients: A phantom study.. 38:64-64. 1997
- Breast cancer detection using vertical axis-of-rotation (VAOR) SPECT with half-cone beam collimation.. 38:936-936. 1997
- Dedicated breast imaging system based on a novel solid state detector array. 38:535-535. 1997
- Dosimetry methods for patients with malignant CNS tumors treated with I-131 81C6 via surgically created cystic resection cavity.. 38:395-395. 1997
- Effects of collimator septal penetration on 511 keV SPECT images. 38:937-937. 1997
- Estimating joint posterior distributions for the volumes and activities of small structures in emission tomography.. 38:934-934. 1997
- Mechanisms of uptake in isolated rat heart of potential radiotherapeutic agent [At-211]meta-astatobenzylguanidine (MABG).. 38:106-106. 1997
- Microdosimetry and small-scale dosimetry of At-211 in bone marrow: An analysis based on histological imaging.. 38:963-963. 1997
- Optimal dose division for two-injection, two-condition FDG PET brain studies.. 38:470-470. 1997
- Survival and DNA damage in V79 cells exposed to the alpha emitters 5-[At-211]astato-2'-deoxy-uridine and [At-211]astatide.. 38:964-964. 1997
- Transmission data acquisition apparatus for a three-headed SPECT system.. 38:933-933. 1997
- Transmission data acquisition with a large field-of-view, dual-headed SPECT system.. 38:935-935. 1997
- Use of an analytic model of pinhole aperture penetration for resolution recovery in I-131 pinhole SPECT.. 38:210-210. 1997
- No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.. 38:330-334. 1997
- Uptake and retention kinetics of para-fluorine-18-fluorobenzylguanidine in isolated rat heart.. 37:2011-2016. 1996
- A method for the radiohalogenation of internalizing antibodies.. 37:1825-1825. 1996
- Radiation absorbed dose estimates for [1-carbon-11]-glucose in adults: the effects of hyperinsulinemia.. 37:1668-1672. 1996
- Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.. 37:1438-1444. 1996
- A quantitative evaluation of 3D PET in FDG brain imaging.. 37:993-993. 1996
- An economic decision analysis of preoperative risk stratification in 6,489 intermediate risk patients undergoing vascular surgery.. 37:45-45. 1996
- An experimental phantom based on quantitative SPECT analysis of patient MIBI biodistribution. 37:676-676. 1996
- Characterization and rejection of annihilation gamma-ray background for a surgical beta ray camera that utilizes positron emitting radiopharmaceuticals. 37:303-303. 1996
- Comparison of subjective image quality of 2D vs 3D acquisition in clinical clinical brain PET.. 37:285-285. 1996
- Correcting for emission contamination in SPECT scanning line source transmission data.. 37:65-65. 1996
- Design of a small scintillation camera with photodiode readout for imaging malignant breast tumors.. 37:200-200. 1996
- Effect of breast size and shape on defect contrast in myocardial perfusion SPECT imaging.. 37:980-980. 1996
- Effects of specific activity on uptake and retention of metaiodobenzylguanidine (MIBG) in the heart: Revisited. 37:701-701. 1996
- Feasibility of pinhole fluorine-18 SPECT of the brain: A Monte Carlo study.. 37:469-469. 1996
- Fluorine-18 labeling of [Nle(4),D-Phe(7)]-alpha-MSH, an alpha-melanocyte stimulating hormone (alpha-MSH) analogue.. 37:875-875. 1996
- Imaging I-131 distributions in brain tumor phantoms with pinhole SPECT.. 37:965-965. 1996
- Impact of image registration on the interpretation of MRI and FDG PET images in patients with known or suspected brain tumors.. 37:76-76. 1996
- Iodine-120-mIBG: Production and NCA labelling of a new PET radiotracer.. 37:874-874. 1996
- Limited-angular-view ML-EM pinhole SPECT for breast tumor detection.. 37:971-971. 1996
- Meta-[At-211]astatobenzylguanidine (MABG): In vivo evaluation in an athymic mouse human neuroblastoma xenograft model.. 37:236-236. 1996
- PET imaging of pheochromocytoma (PHEO) in dogs using PARA [F-18]fluorobenzylguanidine (PFBG).. 37:915-915. 1996
- Preparation and binding properties of an astatine-211 labeled biotin conjugate.. 37:900-900. 1996
- Quantitative SPECT Thallium indices predict outcomes in Emory angioplasty versus surgery trial (EAST).. 37:491-491. 1996
- Stress Thallium SPECT is equally effective for predicting outcomes for women and men in the Emory angioplasty versus surgery trial (EAST).. 37:492-492. 1996
- The relationship of age and maximal oxygen consumption to myocardial blood flow in normal subjects assessed by dipyridamole N-13 ammonia PET.. 37:804-804. 1996
- Half-cone beam collimation for triple-camera SPECT systems.. 37:498-502. 1996
- Localization of technetium-99m-sestamibi in diffuse myelodysplastic processes.. 37:471-473. 1996
- Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.. 36:644-650. 1995
- Evaluation of SPECT quantification of radiopharmaceutical distribution in canine myocardium.. 36:278-286. 1995
- Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.. 35:1771-1776. 1994
- Volume and activity quantitation with iodine-123 SPECT.. 35:1707-1713. 1994
- PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment.. 35:1506-1513. 1994
- Performance characteristics of a whole-body PET scanner.. 35:1398-1406. 1994
- 3-DIMENSIONAL PHOTON SCATTER IN NONUNIFORM MEDIA FOR A SIMULATED TC-99M SPECT MYOCARDIAL PERFUSION STUDY. 35:P17-P17. 1994
- A COMPARISON OF FUNCTIONAL MRI AND H2O-15 PET CHANGES DURING VISUAL-STIMULATION. 35:P32-P32. 1994
- DYNAMIC FDG-PET IMAGING OF FOCAL PULMONARY ABNORMALITIES TO IDENTIFY OPTIMUM TIME FOR IMAGING. 35:P225-P225. 1994
- EXTRAPOLATION OF TRUNCATED PROJECTIONS IN FB-TCT - A QUANTITATIVE APPROACH. 35:P33-P33. 1994
- INCOMPLETE-DATA TREATMENT OF COMPTON SCATTER IN SPECT. 35:P17-P17. 1994
- MEASURED DEFECT CONTRAST WITH SIMULTANEOUS TL-201/TC-99M DUAL-ISOTOPE CARDIAC SPECT. 35:P196-P196. 1994
- MECHANISTIC STUDIES OF METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) UPTAKE AND RETENTION IN ISOLATED RAT-HEART. 35:P57-P57. 1994
- METABOLIC CHARACTERIZATION OF PEDIATRIC PRIMARY BRAIN-TUMORS USING FDG-PET. 35:P44-P44. 1994
- ML-EM VS FBP IN CONVERGING BEAM SPECT - COMPARISON OF AXIAL BLURRING ARTIFACTS REDUCTION USING NONZERO ACTIVITY DISK PHANTOMS. 35:P190-P190. 1994
- MONITORING OF RESPONSE TO NEOADJUVANT THERAPY OF SOFT-TISSUE AND MUSCULOSKELETAL SARCOMAS USING F-18-FDG PET. 35:P38-P38. 1994
- MULTIPINHOLE COLLIMATION FOR SUPERHIGH RESOLUTION, SMALL FIELD-OF-VIEW SPECT. 35:P27-P27. 1994
- MYOCARDIAL AND ADRENAL UPTAKE OF PARA [F-18] FLUOROBENZYLGUANIDINE (PFBG) IN THE DOG. 35:P255-P255. 1994
- PARA[F-18] FLUOROBENZYLGUANIDINE (PFBG) KINETICS IN A CANINE CORONARY-ARTERY OCCLUSION MODEL. 35:P157-P157. 1994
- QUANTITATIVE IMAGING OF AT-211 RADIOTHERAPEUTIC AGENTS IN SMALL VOLUMES. 35:P180-P180. 1994
- QUANTITATIVE MEASUREMENTS FOR SMALL ORGANS OF MONKEY. 35:P179-P179. 1994
- ROC CURVE AND LOGISTIC-REGRESSION ANALYSIS OF VISUAL AND SEMIQUANTITATIVE FDG PET DATA IN THE EVALUATION OF FOCAL PULMONARY ABNORMALITIES. 35:P227-P227. 1994
- SYNTHESIS AND PRELIMINARY EVALUATION OF 4-[F-18]FLUORO-3-IODOBENZYLGUANIDINE (FIBG) - A METAIODOBENZYLGUANIDINE ANALOG FOR PET. 35:P248-P248. 1994
- TE-123M FOR DETERMINATION OF ATTENUATION MAP WITH THE EXISTENCE OF TC-99M IN PATIENTS. 35:P195-P195. 1994
- An evaluation of lesion detectability with cone-beam, fanbeam and parallel-beam collimation in SPECT by continuous ROC study.. 35:135-140. 1994
- Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images.. 34:1998-2006. 1993
- Accuracy of registration of PET, SPECT and MR images of a brain phantom.. 34:1587-1594. 1993
- Fast transmission CT for determining attenuation maps using a collimated line source, rotatable air-copper-lead attenuators and fan-beam collimation.. 34:1577-1586. 1993
- 3-DIMENSIONAL BAYESIAN RECONSTRUCTION FOR SPECT. 34:P20-P20. 1993
- A COMPARISON OF PARALLEL BEAM, FAN BEAM, AND CONE-BEAM COLLIMATORS FOR 3D SPECT BRAIN IMAGING BASED ON MUTUAL INFORMATION CRITERION. 34:P195-P196. 1993
- A FAST ITERATIVE RECONSTRUCTION ALGORITHM FOR CONE-BEAM SPECT. 34:P80-P80. 1993
- A NONUNIFORM ATTENUATION CORRECTION FOR QUANTITATIVE THORAX SPECT BASED ON LUNG EMISSION. 34:P190-P190. 1993
- A POSTRECONSTRUCTION ARTIFICIAL NEURAL-NETWORK FOR COMPENSATION OF COLLIMATOR, ATTENUATION AND SCATTER EFFECTS IN SPECT. 34:P19-P19. 1993
- A STUDY OF RESOLUTION AND SENSITIVITY FOR PARALLEL AND CONE-BEAM COLLIMATORS. 34:P80-P80. 1993
- AN EVALUATION OF LESION DETECTABILITY WITH CONE-BEAM, FAN BEAM AND PARALLEL BEAM COLLIMATION IN SPECT BY CONTINUOUS ROC ANALYSIS. 34:P81-P81. 1993
- DIFFERENTIATION OF BENIGN AND MALIGNANT PULMONARY OPACITIES WITH FDG-PET. 34:P21-P21. 1993
- EFFECT OF INDEX OF REFRACTION ON DETECTOR ELEMENT IDENTIFICATION IN PET BLOCK DETECTORS. 34:P180-P180. 1993
- EVALUATION OF SPECT QUANTIFICATION USING INVIVO DOG STUDIES AND TC-99M LABELED MAA. 34:P26-P26. 1993
- GENERALIZED DUAL-ENERGY WINDOW SCATTER COMPENSATION FOR SPECT. 34:P72-P72. 1993
- IMAGING OSTEOSARCOMA IN DOGS USING F-18 LABELED TP-3 MONOCLONAL-ANTIBODY (MAB) FRAGMENT AND PET. 34:P216-P216. 1993
- INVITRO CYTOTOXICITY OF M-[AT-211]ASTATOBENZYLGUANIDINE (MABG). 34:P218-P218. 1993
- LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC). 34:P99-P100. 1993
- MEASURING ASTATINE-211 DISTRIBUTIONS WITH SPECT. 34:P191-P191. 1993
- NONUNIFORM ATTENUATION COMPENSATION FOR TC-99M CARDIAC SPECT USING ACQUIRED TRANSMISSION DATA. 34:P30-P30. 1993
- PARA[F-18]FLUOROBENZYLGUANIDINE (PFBG) - A POTENTIAL TRACER FOR IMAGING HEART AND TUMOR USING PET. 34:P79-P79. 1993
- PERFORMANCE-CHARACTERISTICS OF A NEW-GENERATION PET SCANNER. 34:P101-P101. 1993
- PINHOLE COLLIMATION FOR ULTRA-HIGH-RESOLUTION, SMALL-FIELD-OF-VIEW SPECT STUDIES. 34:P10-P10. 1993
- THE PREDICTIVE IMPORTANCE OF FDG-PET IN PATIENTS WITH TEMPORAL-LOBE SEIZURES. 34:P23-P23. 1993
- FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.. 34:567-575. 1993
- Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy.. 34:39-47. 1993
- Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography.. 33:1535-1541. 1992
- Standardized tests of PET performance.. 33:1429-1431. 1992
- Fluorine-18-antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model.. 33:575-580. 1992
- An evaluation of maximum likelihood-expectation maximization reconstruction for SPECT by ROC analysis.. 33:451-457. 1992
- Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.. 33:345-350. 1992
- The current role of SPECT in imaging subdural hematoma.. 33:248-250. 1992
- Performance standards in positron emission tomography.. 32:2342-2350. 1991
- Comparison of bicycle and treadmill radionuclide angiocardiography.. 32:1918-1922. 1991
- Brief inhalation method to measure cerebral oxygen extraction fraction with PET: accuracy determination under pathologic conditions.. 32:1738-1741. 1991
- The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.. 32:1518-1525. 1991
- Treatment of Compton scattering in maximum-likelihood, expectation-maximization reconstructions of SPECT images.. 32:1285-1291. 1991
- Quantitative SPECT reconstruction of iodine-123 data.. 32:527-533. 1991
- Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers.. 31:1128-1132. 1990
- Internally administered isotopes in the treatment of solid malignancy.. 31:601-602. 1990
- Technetium-99m labeled NR-LU-10 monoclonal antibody (MoAb) in assessing patients with carcinoma of the lung. 30. 1989
- Utility of FDG-PET in the evaluation of seizures and primary brain tumors. 30. 1989
- Radiation absorbed dose estimates for oxygen-15 radiopharmaceuticals (H2(15)O, C15O, O15O) in newborn infants.. 29:1961-1970. 1988
- SPECT - CURRENT STATUS OF INSTRUMENTATION AND DATE PROCESSING. 29:2026-2026. 1988
- SPECT using a specially designed cone beam collimator.. 29:1398-1405. 1988
- Nonisotropic attenuation in SPECT: phantom tests of quantitative effects and compensation techniques.. 28:1584-1591. 1987
- Inverse Monte Carlo as a unified reconstruction algorithm for ECT.. 27:1577-1585. 1986
- CONE-BEAM SPECT - EXPERIMENTAL VALIDATION USING A CONVENTIONALLY-DESIGNED CONVERGING COLLIMATOR. 27:930-930. 1986
- EXPERIMENTALLY-MEASURED SCATTER FRACTIONS AS A QUANTITATIVE TEST OF MONTE-CARLO SIMULATIONS. 27:960-960. 1986
- INVERSE MONTE-CARLO IMAGE-RECONSTRUCTION FOR SPECT WITH MAXIMUM-LIKELIHOOD-ESTIMATION. 27:895-895. 1986
- Utilization of lung scans by clinicians.. 27:366-369. 1986
- PET: the new focus of nuclear medicine?. 26:1499-1501. 1985
- Factors affecting ventricular volumes determined by a count-based equilibrium method.. 26:1042-1047. 1985
- Research and clinical potential of receptor based radiopharmaceuticals.. 26:655-662. 1985
- Deconvolution of Compton scatter in SPECT.. 26:403-408. 1985
- CORRECTION METHODS AND FACTORS FOR DOSE CALIBRATOR ASSAY OF I-123. 26:P101-P101. 1985
- HIGH-RESOLUTION MRI IMAGING AT 1.5T USING SURFACE COILS. 26:P8-P8. 1985
- Effects of characteristic x-rays on assay of I-123 by dose calibrator.. 25:1367-1370. 1984
- Improved SPECT quantification using compensation for scattered photons.. 25:893-900. 1984
- Disproportionate effects of regional hypokinesis on radionuclide ejection fraction: compensation using attenuation-corrected ventricular volumes.. 25:747-754. 1984
- In-111 platelet scintigraphy: carotid atherosclerosis and stroke.. 25:626-629. 1984
- ATTENUATION COEFFICIENTS FOR TC-99M PHOTONS IN WATERFILLED PHANTOMS, DETERMINED WITH A GAMMA-CAMERA - VARIATION WITH ENERGY WINDOW. 25:P22-P23. 1984
- EVALUATION OF SPECT SYSTEM PERFORMANCE BY QUANTATATIVELY COMPARING PLANAR AND RECONSTRUCTED SPATIAL RESOLUTIONS. 25:P107-P108. 1984
- MONTE-CARLO EVALUATION OF COMPTON SCATTER COMPENSATION BY DEONVOLUTION IN SPECT. 25:P71-P71. 1984
- THE ESTIMATION OF SPECT STATISTICAL RELIABILITY. 25:P70-P70. 1984
- VARIATIONS IN ATTENUATION COEFFICIENTS FOR TC-99M PHOTONS WITH SOURCE DEPTH AND REGION-OF-INTEREST SIZE. 25:P23-P23. 1984
- Tl-201 single-photon emission computed tomography (SPECT).. 24:273-275. 1983
- THE SUBTRACTION OF SCATTERED EVENTS FROM SPECT PHOTOPEAK EVENTS. 24:P82-P82. 1983
- TI-201 SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY (SPECT) - REPLY. 24:273-274. 1983
- Comparison of 180 degrees and 360 degrees data collection in thallium-20 1 imaging using single-photon emission computerized tomography (SPECT): concise communication.. 23:655-660. 1982
- Imaging of brain tumors after administration of L-(N-13)glutamate: concise communication.. 23:682-687. 1982
- Studying regional brain function: a challenge for SPECT.. 23:266-270. 1982
- Human platelets labeled with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of radiation dose.. 23:149-156. 1982
- Lesion detection with single-photon emission computed tomography (SPECT) compared with conventional imaging.. 23:97-102. 1982
- DIAGNOSIS OF ALCOHOLIC CIRRHOSIS WITH THE RIGHT-TO-LEFT HEPATIC LOBE RATIO - CONCISE COMMUNICATION. 23:80-80. 1982
- Improved diagnosis of renal osteodystrophia by the use of Tc-99m MDP bone clearance. 23. 1982
- Re:diagnosis of alcoholic cirrhosis with the right-to-left hepatic lobe ratio: concise communication.. 23:80. 1982
- THE EFFECT OF SOURCE MOTION ON LESION CONTRAST WITH SPECT AND CONVENTIONAL IMAGING. 23:P44-P45. 1982
- LESION DETECTABILITY OF ROTATING CAMERA-BASED SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY (SPECT). 22:P39-P39. 1981
- THALLIUM STUDIES USING SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY (SPECT). 22:P11-P11. 1981
- Imaging of the human heart after administration of L-(N-13)glutamate.. 21:988-991. 1980
- Correction for field nonuniformity in scintillation cameras through removal of spastial distortion.. 21:771-776. 1980
- Site of Tc-99m binding to the red blood cell: concise communication.. 21:676-678. 1980
- BREMSSTRAHLUNG IMAGING OF INTRAPERITONEAL P-32 DISTRIBUTIONS. 21:P33-P33. 1980
- LEFT-VENTRICULAR VOLUME USING ATTENUATION-CORRECTED MULTIGATED DATA. 21:P50-P50. 1980
- A new container geometry for better sensitivity in radiometric measurements.. 20:1090-1092. 1979
- Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate.. 20:782-784. 1979
- Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma.. 20:303-305. 1979
- Nitrogen-13 nitrous oxide for cerebral imaging studies. 19:700. 1978
- Radionuclide emission computed tomography of the head with 99mCc and a scintillation camera.. 18:373-380. 1977
- Increased resolving power from scintillation cameras using electronic signal processing and a movable filter plate.. 14:14-20. 1973
- Elementary radiation dosimetry.. 8:370. 1967
- Inferring the causality network of Abeta and Tau accumulation in the aging brain: a statistical inference approach 2017
- Endogenous versus Exogenous Ketosis to Suppress Myocardial Glucose Uptake on FDG-PET: KEETO-CROSS 2021
- Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts 2021
- N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[I-131]iodobenzmide ([I-131]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments. 2020
- NOVEL METHODOLGY FOR MEASURING REGIONAL MYOCARDIAL EFFICIENCY 2020
- IN VIVO MEASURE OF CARDIAC EFFICIENCY USING HYBRID PET/MRI TECHNOLOGY 2019
- PSMA-targeted alpha therapeutic agent with fast kidney clearance 2019
- The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study 2019
- F-18-labeling of an anti-HER2 sdAb with a renal brush border enzyme-cleavable linker-containing prosthetic agent via a trans-cyclooctene (TCO)-terazine (Tz) inverse electron-demand Diels-Alder reaction (IEDDAR) for reduced renal uptake 2018
- Sensitivity of various FDG PET-CT SUV thresholds for round atelectasis 2018
- Simplified At-211-labeling of internalizing proteins by preconjugation with the tin precursor of a residualizing prosthetic agent: Application to an anti-HER2 single domain antibody fragment 2018
- Small Molecule Radiohalogenated (I-125/At-211), DOTA Containing PSMA Inhibitors: Metal Complexation and Competing Inhibitor Improve Biodistribution in Mice 2018
- Imaging spectrum of medical refractory temporal lobe epilepsy on PET and MRI with pathologic correlation 2018
- Feasibility of 124I anti-PD-L1 PET/CT imaging in a syngeneic tumor model of breast cancer. 2017
- Labeling an anti-HER2 VHH with F-18 using a residualizing prosthetic group via strain-promoted click reaction: preliminary evaluation 2017
- 211At-Labeled Small-Molecule PSMA Inhibitors: Effect of Structure on Biodistribution in Mice 2016
- Comparison of Q.Clear (regularized) reconstruction versus OS-EM for characterization of small lesions in oncologic PET/CT 2016
- Dual 18F-fluorodeoxyglucose/68Gallium DOTATATE (FDG/DOTA) PET grading and histological grade in neuroendocrine tumours (NET) 2016
- Improved survival in 211 patients with stage IV carcinoid tumor treated with high dose I-131 MIBG is predicted by response at initial follow up and by multiple rounds of I-131 MIBG. 2016
- SPECT/CT Imaging of Prostatic PSMA Expression with Tc99m trofolastat chloride in Healthy Volunteers 2016
- [211At]YC-I-27 for PSMA-Targeted Alpha-Particle Radiopharmaceutical Therapy 2016
- Characterization of anti-Frizzled Antibody [Zr-89]18R5 for PET Imaging of Pancreatic Cancer 2016
- A At-211-labeled nanobody for alpha-particle therapy of HER2-expressing cancers 2015
- Preclinical development of Meta-[At-211]astatobenzylguanidine ([At-211]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma (NB). 2015
- PET lesion quantitation noise estimates from sub-scan images 2014
- Prognostic value of CZT SPECT camera in cardiac imaging 2014
- Radioiodinated AGI-5198 for in vivo imaging of isocitrate dehydrogenase 1 (IDH1) mutation in gliomas 2014
- Validity of two-day lymphoscintigraphy for detection of lymphatic basins 2014
- Changes in detected scatter distribution using nontraditional orbits in dedicated breast SPECT 2014
- Changes in detected scatter distribution using nontraditional orbits in dedicated breast SPECT 2014
- Translocator protein (TSPO) as an imaging target in pancreatic cancer 2013
- Effects of attenuation map type and alignment for quantifying dedicated breast SPECT-CT images 2012
- Initial quantification of MIBI concentration in asymptomatic breast tissue with a dedicated SPECT-CT breast imaging system 2012
- Iodoquine as a potential PET radiolabel for in vivo cell trafficking of leukocyte tumor cell lines 2012
- Modular nanotransporters: A flexible platform forward for targeted Auger electron therapy 2012
- A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[18F]pentafluoropropyl)-acetamide([18F]EF5) 2011
- An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine 2011
- Improved quantification and image quality in dedicated breast SPECT using conical resolution recovery reconstruction models 2011
- Methylphenidate induced dopamine increases in striatum and temporal and frontal cortices predicts response to treatment in ADHD 2011
- Disruption of Functional Brain Connections in Alzheimer's Disease 2010
- VirtualDose: A CT dose reporting software based on anatomically realistic phantoms 2010
- Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate 2010
- A comparative study of procedure times for pharmacologic studies in myocardial perfusion imaging 2009
- An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma 2009
- Chronic treatment with methylphenidate increases dopamine transporter density in patients with attention deficit hyperactive disorder 2009
- Characterization of Discovery ST and advance PET systems using a whole-body phantom. 2003
- Convection enhanced delivery of TP-38 immunotoxin for the therapy of brain tumors: Assessment of delivery and distribution by means of registered SPECT and MRI. 2003
- Impact of partial volume correction on small malignant lung nodules. 2003
- The effects of mechanical and electronic shifts on pinhole SPECT resolution. 2003
- Impact of CT fusion on camera-based PET (CBPET) for clinical oncology applications. 2001
- Efficiency comparison between Tc-99m tetrofosmin and Tc-99m sestamibi myocardial perfusion studies. 2000
- Comparison of rest and physical exercise stress F-18 FDG myocardial PET studies in patients with diminished left ventricular ejection fraction. 1998
- Estimation of perfusion and oxygen utilization rate in tumors with PET: A technique without arterial blood sampling. 1998
- FACILE SYNTHESIS OF C-11 LABELED CITALOPRAM FOR PET STUDIES OF SEROTONIN UPTAKE SITES 1989
- SYNTHESIS OF [C-11] LABELED TAMOXIFEN VIA REDUCTIVE CARBOXYLATION 1988
- N-13 NITROUS-OXIDE FOR CEREBRAL IMAGING STUDIES 1978

Publication Venue For